Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf M Huber

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Breathe (Sheffield, England)|December 6, 2019
Continuous professional development: elevating thoracic oncology education in EuropeWouter H van Geffen, Torsten G Blum, Stefano Aliberti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease small-cell lung cancer: final results of a randomized phase III trialThomas H Fink, Rudolf M Huber, David F Heigener, et al.
Respiratory Research|January 15, 2017
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohortKathrin Kahnert, Tanja Lucke, Frank Biertz, et al.
Plos One|May 16, 2017
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohortKathrin Kahnert, Tanja Lucke, Rudolf M Huber, et al.
Respiratory Medicine|February 8, 2018
The revised GOLD 2017 COPD categorization in relation to comorbiditiesKathrin Kahnert, Peter Alter, David Young, et al.
Translational Lung Cancer Research|September 22, 2016
From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert PanelChunxia Su, Mathias Meyer, Robert Pirker, et al.
Breathe (Sheffield, England)|February 18, 2017
Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncologyFernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, et al.
Clinical Lung Cancer|June 29, 2025
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation StatusLyudmila Bazhenova, J G Hodgson, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 5, 2021
Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee ReportRudolf M Huber, Milena Cavic, Anna Kerpel-Fronius, et al.
Oncology Research and Treatment|May 24, 2014
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, GermanyDieter Hörsch, Kurt W Schmid, Martin Anlauf, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Breathe (Sheffield, England)|December 6, 2019
Continuous professional development: elevating thoracic oncology education in EuropeWouter H van Geffen, Torsten G Blum, Stefano Aliberti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease small-cell lung cancer: final results of a randomized phase III trialThomas H Fink, Rudolf M Huber, David F Heigener, et al.
Respiratory Research|January 15, 2017
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohortKathrin Kahnert, Tanja Lucke, Frank Biertz, et al.
Plos One|May 16, 2017
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohortKathrin Kahnert, Tanja Lucke, Rudolf M Huber, et al.
Respiratory Medicine|February 8, 2018
The revised GOLD 2017 COPD categorization in relation to comorbiditiesKathrin Kahnert, Peter Alter, David Young, et al.
Translational Lung Cancer Research|September 22, 2016
From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert PanelChunxia Su, Mathias Meyer, Robert Pirker, et al.
Breathe (Sheffield, England)|February 18, 2017
Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncologyFernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, et al.
Clinical Lung Cancer|June 29, 2025
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation StatusLyudmila Bazhenova, J G Hodgson, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 5, 2021
Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee ReportRudolf M Huber, Milena Cavic, Anna Kerpel-Fronius, et al.
Oncology Research and Treatment|May 24, 2014
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, GermanyDieter Hörsch, Kurt W Schmid, Martin Anlauf, et al.
Pageof 11